Lower airway inflammation before and after house dust mite nasal challenge: An age and allergen exposure-related phenomenon

Respiratory Medicine

Volumn 101, Issue 7, 2007, Pages 1600-1608

  Marcucci, F ^a   Passalacqua, G ^b   Canonica, G W ^b   Frati, F ^a   Salvatori, S ^a   Di cara, G ^a   Petrini, I ^a   Bernini, M ^a   Novembre, E ^c   Bernardini, R ^c   Incorvaia, C ^d   Sensi, L G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ICP Hospital   (Italy)

Author keywords

Allergen specific nasal challenge; Bronchial inflammation; Exhaled nitric oxide; House dust mite; Sputum ECP; Upper and lower airways

Indexed keywords

CETIRIZINE; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; MEPREDNISONE; NITRIC OXIDE; SALBUTAMOL; TRYPTASE;

ARTICLE; ASTHMA; BRONCHITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; NOSE PROVOCATION TEST; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; RHINITIS; SCORING SYSTEM; SEASONAL VARIATION; SPUTUM LEVEL;

ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; DERMATOPHAGOIDES PTERONYSSINUS; EOSINOPHIL CATIONIC PROTEIN; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; NASAL PROVOCATION TESTS; NITRIC OXIDE; PEAK EXPIRATORY FLOW RATE; RHINITIS; SEASONS; SKIN TESTS; SPUTUM; TRYPTASES;

EID: 34249777544     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.06.006     Document Type: Article

References (28)

1. Bousquet J., Van Cauwenberge P., Khaltaev N., and and the WHO panel. Allergic rhinitis and its impact on asthma. ARIA. In collaboration with the World Health Organization. J Allergy Clin Immunol 108 (2001) S1-S315
2. Ten Brinke A., Grootendorst D.C., Schmidt J., et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109 (2002) 621-624
3. Moloney J.R., and Collins J. Nasal polyps and bronchial asthma. Br J Dis Chest 71 (1977) 1-6
4. Sedgwick J.B., Calhoun W.J., Gleich G.J., et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 144 (1991) 1274-1281
5. Braunstahl G.J., Kleinjan A., Overbeek S.E., Prins J.B., Hoogsteden H.C., and Fokkens W.J. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 161 (2000) 2051-2057
6. Braunstahl G.J., Overbeek S.E., Kleinjan A., Prins J.B., Hoogsteden H.C., and Fokkens W.J. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107 (2001) 469-476
7. Bonay M., Neukirch C., Grandsaigne M., Lecon-Malas V., Ravaud P., Dehoux M., et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy 61 (2006) 111-118
8. Tatar M., Petriskova J., Zucha J., Pecova R., Hutka Z., Raffajova J., et al. Induced sputum eosinophils, bronchial reactivity, and cough sensitivity in subjects with allergic rhinitis. J Physiol Pharmacol 56 Suppl 4 (2005) 227-236
9. Beeh K.M., Beier J., Kornmann O., Meier C., Taeumer T., and Buhl R. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 33 (2003) 475-482
10. Polosa R. Bronchial hyperresponsiveness and airway inflammation markers in non-asthmatics with allergic rhinitis. Eur Respir J 15 (2000) 30-35
11. Wang D.Y., Goh D.Y.T., Ho A.K.L., Chew F.T., Yeoh K.H., and Lee B.W. The upper and lower airway response to nasal challenge with house-dust mite Blomia tropicalis. Allergy 58 (2003) 78-82
12. Henriksen J., and Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Resp Dis 130 (1984) 1014-1018
13. Reed C.E., Marcoux J.P., and Welsh P.W. Effects of topical nasal treatment on asthma symptoms. J Allergy Clin Immunol 81 5 pt 2 (1988 May) 1042-1047
14. Aubier M., Levy J., Clerici C., Neukirch F., and Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 146 1 (1992 Jul) 122-126
15. Dahl R., Baker R.C., and Pauwels R. Seasonal rhinitis and asthma. Effects of topical nasal and/or orally inhaled fluticasone propionate. The SPIRA Study. J Allergy Clin Immunol 107 (2001) S154
16. Global Initiative for Asthma. Global strategy for asthma management and prevention, revised 2002. National Institute of Health. NIH Publication No. 02-3659.
17. Marcucci F., and Sensi L. A new method for IgE detection in nasal mucosa. Clin Exp Allergy 19 2 (1989) 157-162
18. Sensi L.G., Seri A., Siracusa A., Pertici A., and Marcucci F. Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. Clin Exp Allergy 27 (1997) 270-276
19. Marcucci F., Sensi L., Frati F., et al. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 56 (2001) 1091-1095
20. Fujimoto K., Kubo K., Matsuzawa Y., and Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest 112 (1997) 1241-1247
21. Lopuhaa C.E., Out T.A., Jansen H.M., Aalberse R.C., and Van der Zee J.S. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma. Clin Exp Allergy 32 (2002) 1720-1727
22. Platts-Mills T.A., Hayden M.L., Chapman M.D., and Wilkins S.R. Seasonal variation in dust mite and grass-pollen allergens in dust from the houses of patients with asthma. J Allergy Clin Immunol 79 (1987) 781-791
23. Wang D.Y., Duyck F., Smitz J., and Clement P. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophils count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis. Allergy 53 (1998) 375-382
24. Wang D.Y., Smitz L., Waterschoot S., and Clement P. An approach to the understanding of the nasal early-phase reaction induced by nasal allergen challenge. Allergy 52 (1997) 162-167
25. Wang D.Y., and Clement P. Pathogenic mechanism underlying the clinical symptoms of allergic rhinitis. Am J Rhinol 14 (2000) 325-333
26. Lamblin C., Gosset P., Tillie-Leblond I., et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 157 (1998) 394-402
27. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., and Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161 (2000) 9-16
28. Hoyne G.F., Tan K., Corsin-Jimenez M., et al. Immunological tolerance to inhaled antigen. Am J Crit Care Med 162 (2000) S169-S174